Consumer ad spend is bright spot for media owners

Share this article:
Pharmaceutical spending on consumer ads is a rare bright spot for media owners this year, but newspapers are getting short shrift. Spending for the drugs and remedies sector is up 8% for the year so far, according to Universal McCann. But spending on newspaper ads for Rx drugs is down a whopping 188% and outdoor ads slumped a surprising 82%, according to TNS Media Intelligence.
Share this article:

Email Newsletters

More in News

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Valeant bids $47B for Allergan

Valeant bids $47B for Allergan

The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.